Lucid Diagnostics (LUCD) Competitors $1.10 +0.05 (+4.76%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.15 +0.05 (+4.55%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD vs. TMCI, DCTH, BFLY, RXST, SNWV, CLPT, NPCE, DRTS, TCMD, and SKINShould you be buying Lucid Diagnostics stock or one of its competitors? The main competitors of Lucid Diagnostics include Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), Sanuwave Health (SNWV), ClearPoint Neuro (CLPT), NeuroPace (NPCE), Alpha Tau Medical (DRTS), Tactile Systems Technology (TCMD), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry. Lucid Diagnostics vs. Its Competitors Treace Medical Concepts Delcath Systems Butterfly Network RxSight Sanuwave Health ClearPoint Neuro NeuroPace Alpha Tau Medical Tactile Systems Technology Beauty Health Lucid Diagnostics (NASDAQ:LUCD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment. Does the media refer more to LUCD or TMCI? In the previous week, Lucid Diagnostics had 4 more articles in the media than Treace Medical Concepts. MarketBeat recorded 5 mentions for Lucid Diagnostics and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.67 beat Lucid Diagnostics' score of 1.05 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lucid Diagnostics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is LUCD or TMCI more profitable? Treace Medical Concepts has a net margin of -23.01% compared to Lucid Diagnostics' net margin of -1,476.35%. Lucid Diagnostics' return on equity of 0.00% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Lucid Diagnostics-1,476.35% N/A -120.43% Treace Medical Concepts -23.01%-46.76%-23.35% Which has more volatility & risk, LUCD or TMCI? Lucid Diagnostics has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Do analysts prefer LUCD or TMCI? Lucid Diagnostics currently has a consensus target price of $3.55, suggesting a potential upside of 222.73%. Treace Medical Concepts has a consensus target price of $9.83, suggesting a potential upside of 27.71%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, equities analysts plainly believe Lucid Diagnostics is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Treace Medical Concepts 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do institutionals and insiders hold more shares of LUCD or TMCI? 74.0% of Lucid Diagnostics shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 6.8% of Lucid Diagnostics shares are held by insiders. Comparatively, 27.7% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better earnings and valuation, LUCD or TMCI? Lucid Diagnostics has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLucid Diagnostics$4.35M27.43-$45.53M-$1.19-0.92Treace Medical Concepts$209.36M2.32-$55.74M-$0.79-9.75 SummaryLucid Diagnostics beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks. Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUCD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCD vs. The Competition Export to ExcelMetricLucid DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$119.32M$7.12B$5.83B$9.78BDividend YieldN/A1.28%4.40%4.05%P/E Ratio-0.9227.4531.3026.05Price / Sales27.4375.21455.25117.77Price / CashN/A21.9338.0259.36Price / Book-2.566.889.536.60Net Income-$45.53M$176.42M$3.26B$265.65M7 Day Performance7.84%1.45%2.14%2.01%1 Month Performance-1.79%-2.71%2.81%-0.33%1 Year Performance34.31%9.40%30.70%19.04% Lucid Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCDLucid Diagnostics3.0933 of 5 stars$1.10+4.8%$3.55+222.7%+29.9%$119.32M$4.35M-0.9270Insider TradeTMCITreace Medical Concepts2.5992 of 5 stars$7.04+2.2%$9.83+39.7%+24.2%$435.26M$209.36M-8.91250DCTHDelcath Systems2.7876 of 5 stars$10.65+2.8%$24.50+130.0%+41.3%$362.41M$37.21M213.0060Short Interest ↑BFLYButterfly Network2.9508 of 5 stars$1.44+0.7%$3.00+108.3%+68.9%$359.99M$82.06M-5.14460RXSTRxSight0.9843 of 5 stars$8.49+0.7%$10.00+17.8%-82.9%$344.92M$139.93M-10.61220Trending NewsShort Interest ↑SNWVSanuwave Health1.4415 of 5 stars$38.36-0.6%$49.00+27.7%N/A$330.81M$32.63M-4.6540Positive NewsAnalyst ForecastCLPTClearPoint Neuro1.8846 of 5 stars$11.22-2.9%$19.67+75.3%-5.9%$328.34M$31.39M-13.85110NPCENeuroPace3.4705 of 5 stars$8.42-1.6%$16.60+97.1%+28.2%$283.18M$79.91M-10.02170Short Interest ↑DRTSAlpha Tau Medical2.7809 of 5 stars$3.26-0.6%$9.00+176.1%+41.7%$278.21MN/A-6.7980News CoverageTCMDTactile Systems Technology2.4647 of 5 stars$12.58+1.4%$13.50+7.3%+6.2%$276.64M$298.85M20.291,037Positive NewsSKINBeauty Health1.0073 of 5 stars$2.19+0.5%$2.63+19.9%+46.4%$276.48M$334.30M-7.821,030Positive News Related Companies and Tools Related Companies TMCI Alternatives DCTH Alternatives BFLY Alternatives RXST Alternatives SNWV Alternatives CLPT Alternatives NPCE Alternatives DRTS Alternatives TCMD Alternatives SKIN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCD) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access